scholarly journals IKKα mediates UVB-induced cell apoptosis by regulating p53 pathway activation

2021 ◽  
Vol 227 ◽  
pp. 112892
Author(s):  
Hongli Wang ◽  
Min Zhang ◽  
Xiuduan Xu ◽  
Shaojun Hou ◽  
Zhihui Liu ◽  
...  
2018 ◽  
Vol 504 (1) ◽  
pp. 123-128 ◽  
Author(s):  
Jianhao Xu ◽  
Cunjin Su ◽  
Fenglun Zhao ◽  
Jialong Tao ◽  
Duanmin Hu ◽  
...  

2021 ◽  
Vol 16 (1) ◽  
pp. 537-543
Author(s):  
Mei Zhang ◽  
Jing Yuan ◽  
Rong Dong ◽  
Jingjing Da ◽  
Qian Li ◽  
...  

Abstract Background Hyperhomocysteinemia (HHcy) plays an important role in the progression of many kidney diseases; however, the relationship between HHcy and ischemia-reperfusion injury (IRI)-induced acute kidney injury (IRI-induced AKI) is far from clear. In this study, we try to investigate the effect and possible mechanisms of HHcy on IRI-induced AKI. Methods Twenty C57/BL6 mice were reared with a regular diet or high methionine diet for 2 weeks (to generate HHcy mice); after that, mice were subgrouped to receive sham operation or ischemia-reperfusion surgery. Twenty four hour after reperfusion, serum creatinine, blood urea nitrogen, and Malondialdehyde (MDA) were measured. H&E staining for tubular injury, western blot for γH2AX, JNK, p-JNK, and cleaved caspase 3, and TUNEL assay for tubular cell apoptosis were also performed. Results Our results showed that HHcy did not influence the renal function and histological structure, as well as the levels of MDA, γH2AX, JNK, p-JNK, and tubular cell apoptosis in control mice. However, in IRI-induced AKI mice, HHcy caused severer renal dysfunction and tubular injury, higher levels of oxidative stress, DNA damage, JNK pathway activation, and tubular cell apoptosis. Conclusion Our results demonstrated that HHcy could exacerbate IRI-induced AKI, which may be achieved through promoting oxidative stress, DNA damage, JNK pathway activation, and consequent apoptosis.


Author(s):  
Adam N.R. Cartwright ◽  
Shengbao Suo ◽  
Soumya Badrinath ◽  
Sushil Kumar ◽  
Johannes Melms ◽  
...  

RSC Advances ◽  
2020 ◽  
Vol 10 (50) ◽  
pp. 29780-29788
Author(s):  
Yuebing Ren ◽  
Haibo Song ◽  
Yuanpeng Wu ◽  
Xiaochun Ma ◽  
Xuezhong Yu ◽  
...  

CO-10 induced cell apoptosis with mitochondria dysfunction and caspases, ASK1-MAPKs pathway activation.


Blood ◽  
2005 ◽  
Vol 106 (11) ◽  
pp. 3382-3382
Author(s):  
Thorsten Stühmer ◽  
Angela Zöllinger ◽  
Manik Chatterjee ◽  
Kurt Bommert ◽  
Ralf C. Bargou

Abstract The p53 pathway is central to cellular defences against neoplastic transformation, and mutations that impair p53 function are prominent oncogenic events. However, certain malignancies, such as multiple myeloma (MM), rarely present with p53 defects except in late stages. MM might therefore be vulnerable to p53 induction therapy, but it is unknown if the p53 pathway remains actually functional in this disease, and if it can be sufficiently well triggered to induce tumor cell death. We have used nutlin-3, a newly developed small-molecule antagonist against the p53 suppressor murine double minute 2 (MDM2), to analyze the effect on myeloma cell lines and a large panel of patient tumor samples. Nutlin-3 specifically and exclusively induced p53 downstream targets in myeloma cells with wild-type p53, and a large majority of primary medullary myeloma samples was susceptible to nutlin-3-mediated apoptosis. Comparison with the clinically relevant genotoxic drugs melphalan and etoposide showed that nutlin-3 was as effective or better at inducing apoptosis of primary tumor cells, and that combinations of nutlin-3 with genotoxic cytostatics at low doses produced better than additive anti-tumor effects. Importantly, broad anti-tumor activity of nutlin-3 persisted even when primary tumor cells were kept in coculture with bone marrow stromal cells (BMSCs). However, primary tumor isolates often contain a fraction of cells apparently unaffected by drug treatment, and some primary samples were conspicuously less sensitive to nutlin exposure when the cells were kept in coculture with BMSCs, as compared to culture in medium supplemented with interleukin-6. We have begun to analyze to what extent heterogeneity for p53 induction within the tumor cell population may underlie these differences, and if the capacity to activate intracellular growth and survival pathways has an influence on the result of p53 pathway activation. Nutlin-3, as a non-genotoxic agent to specifically induce or strengthen p53-mediated apoptotic responses may be a promising agent to complement standard genotoxic regimens for the treatment of MM.


2004 ◽  
Vol 6 (2) ◽  
pp. 127-138 ◽  
Author(s):  
Chun-Ling Zhang ◽  
Li-Jun Wu ◽  
Shin-Ichi Tashiro ◽  
Satoshi Onodera ◽  
Takashi Ikejima

2019 ◽  
Vol 514 (2) ◽  
pp. 401-406 ◽  
Author(s):  
Rui-Yuan Xu ◽  
Xing-Wang Xu ◽  
Yi-Zhang Deng ◽  
Zhao-Xia Ma ◽  
Xiao-Ran Li ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document